Resonancia magnética de dos pacientes con miocardiopatía dilatada. A la izquierda, paciente con fibrosis sin canales de conducción y a la derecha, paciente con múltiples canales.
    Research, Publications
    Circulation: A study led by Spanish scientists identifies dilated cardiomyopathy patients at greater risk of sudden death and arrhythmias[

    The findings could help more precisely identify candidates for a preventive implantable defibrillator

    Pablo García Pavía y Nerea Mora.
    Research, Publications
    Circulation: Largest genetic and MRI study carried out to date rules out the existence of heart disease

    Left ventricular hypertrabeculation, an anatomical feature of the heart traditionally linked to higher risk, does not worsen outcomes in patients with dilated cardiomyopathy

    Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
    Research, Publications
    CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure

    The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.

    José Luis de la Pompa, Blanca Rubio, Rocío Serrano, Laura Lalaguna, Pablo García Pavía, María López Olañeta y Enrique Lara.
    Research, Publications
    European Heart Journal: CNIC scientists report the first use of CRISPR activation to treat a cardiac disease in mice

    The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases

    •  
    • 1 of 3